Olivier Feron
Olivier Feron
Verified email at uclouvain.be
TitleCited byYear
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, FC Abdalla, H Abeliovich, RT Abraham, A Acevedo-Arozena, ...
Autophagy 8 (4), 445-544, 2012
6011*2012
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
DJ Klionsky, H Abeliovich, P Agostinis, DK Agrawal, G Aliev, DS Askew, ...
Autophagy 4 (2), 151-175, 2008
23592008
To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
F Danhier, O Feron, V Préat
Journal of controlled release 148 (2), 135-146, 2010
17652010
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
P Sonveaux, F Végran, T Schroeder, MC Wergin, J Verrax, ZN Rabbani, ...
The Journal of clinical investigation 118 (12), 3930-3942, 2008
11272008
Nitric oxide synthases: which, where, how, and why?
T Michel, O Feron
The Journal of clinical investigation 100 (9), 2146-2152, 1997
11131997
Endothelial nitric oxide synthase targeting to caveolae specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells
O Feron, L Belhassen, L Kobzik, TW Smith, RA Kelly, T Michel
Journal of Biological Chemistry 271 (37), 22810-22814, 1996
7711996
Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin
JB Michel, O Feron, D Sacks, T Michel
Journal of Biological Chemistry 272 (25), 15583-15586, 1997
6551997
Nitric oxide and cardiac function: ten years after, and continuing
PB Massion, O Feron, C Dessy, JL Balligand
Circulation research 93 (5), 388-398, 2003
6372003
Hydroxy-methylglutaryl–coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance
O Feron, C Dessy, JP Desager, JL Balligand
Circulation 103 (1), 113-118, 2001
5702001
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation
F Danhier, N Lecouturier, B Vroman, C Jérôme, J Marchand-Brynaert, ...
Journal of controlled release 133 (1), 11-17, 2009
5162009
Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells
O Feron
Radiotherapy and oncology 92 (3), 329-333, 2009
4512009
eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues
JL Balligand, O Feron, C Dessy
Physiological reviews 89 (2), 481-534, 2009
4512009
Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
O Feron, C Dessy, S Moniotte, JP Desager, JL Balligand
The Journal of clinical investigation 103 (6), 897-905, 1999
4441999
Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis
F Végran, R Boidot, C Michiels, P Sonveaux, O Feron
Cancer research 71 (7), 2550-2560, 2011
4352011
The endothelial nitric-oxide synthase-caveolin regulatory cycle
O Feron, F Saldana, JB Michel, T Michel
Journal of Biological Chemistry 273 (6), 3125-3128, 1998
4161998
Upregulation of β3-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium
S Moniotte, L Kobzik, O Feron, JN Trochu, C Gauthier, JL Balligand
Circulation 103 (12), 1649-1655, 2001
3782001
Caveolin versus calmodulin counterbalancing allosteric modulators of endothelial nitric oxide synthase
JB Michel, O Feron, K Sase, P Prabhakar, T Michel
Journal of Biological Chemistry 272 (41), 25907-25912, 1997
3761997
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel
F Danhier, B Vroman, N Lecouturier, N Crokart, V Pourcelle, H Freichels, ...
Journal of Controlled Release 140 (2), 166-173, 2009
3342009
Hsp90 and caveolin are key targets for the proangiogenic nitric oxide–mediated effects of statins
A Brouet, P Sonveaux, C Dessy, S Moniotte, JL Balligand, O Feron
Circulation research 89 (10), 866-873, 2001
3272001
Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes
O Feron, TW Smith, T Michel, RA Kelly
Journal of Biological Chemistry 272 (28), 17744-17748, 1997
3101997
The system can't perform the operation now. Try again later.
Articles 1–20